FDA Adverse Event Malfunction Summary report: N

ANALYTICAL E MODULE

MDR report key: 1904953 · Received November 22, 2010

Report

Report Number
1823260-2010-06861
Event Type
Malfunction
Date Received
November 22, 2010
Date of Event
November 1, 2010
Report Date
January 7, 2011
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
PMA / PMN Number
K961481
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NJ, US
Reporter Occupation
MEDICAL TECHNOLOGIST

Narratives

Additional Manufacturer Narrative · 1

A SPECIFIC ROOT CAUSE COULD NOT BE IDENTIFIED. CALIBRATION AND QUALITY CONTROLS WERE ACCEPTABLE. IT WAS NOTED THE CUSTOMER MAY HAVE INTRODUCED AIR BUBBLES INTO THE SAMPLE WHILE POURING THE SAMPLE INTO THREE ALIQUOTS. POURING OF SAMPLES IS NOT RECOMMENDED. THIS IS MOST LIKELY THE CAUSE OF THE EVENT. THE PATIENT WAS NOT ADVERSELY AFFECTED.

Description of Event or Problem · 1

THE USER RECEIVED A QUESTIONABLE INTACT HUMAN CHORIONIC GONADOTROPIN + SS-SUBUNIT (HCG+SS) RESULT FOR ONE PATIENT SAMPLE. THE INITIAL RESULT WAS 0.100 MIU/ML WITH A DATA FLAG AND WAS REPORTED OUTSIDE THE LABORATORY. THE DOCTOR CALLED THE LABORATORY AND REQUESTED A VALIDITY CHECK ON THE SAMPLE. ON (B)(6) 2010, THE SAMPLE WAS REPEATED ON A MODULE NAMED "E9-1" AND THE RESULTS WERE 79826 (1:100 DILUTION), 10000, 84208 (1:100 DILUTION) AND 10000 MIU/ML. ALL THE REPEAT RESULTS WERE ACCOMPANIED BY DATA FLAGS. THE SAMPLE WAS ALSO REPEATED ON A MODULE NAMED "E9-2" AND THE RESULTS WERE 10000, 88957 (1:100 DILUTION), 10000 AND 78910 (1:100 DILUTION) MIU/ML. ALL THE REPEAT RESULTS WERE ACCOMPANIED BY DATA FLAGS. THE PATIENT WAS NOT ADVERSELY AFFECTED. THE HCG+SS REAGENT LOT NUMBER WAS 15851502. THE FIELD SERVICE REPRESENTATIVE FOUND THE SAMPLE CONTAINED FIBRIN PARTICLES. HE RAN INSTRUMENTS CHECKS, CALIBRATION, QUALITY CONTROL AND SAMPLES TO VERIFY THE ANALYZER OPERATION. HE OBSERVED ALL CHECKS AND SAMPLES FOR PARTICLES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ANALYTICAL E MODULE IMMUNOCHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS NA NA

Patients

Seq Age Sex Outcome Treatment
1 020 YR